Kiniwa et al. determined that regulatory T cells (CD8+ Foxp3+ or CD4+CD25+) present in prostate tumors mediate immunosuppression by suppressing naive T cell proliferation[57]. This evidence concerns the gene CD4 and prostate neoplasm.